VA PRIME Care Study Evaluates Pharmacogenomic Tests

Access to Myriad Genetics’ GeneSight test improves depression remission rates according to a new nationwide study of nearly 2,000 veterans conducted by the U.S. Department of Veterans Affairs (VA).

Read the news release

Videos

GeneSight B-Roll

Genesight is incredibly beneficial for difficult to treat patients

Soundbites from GeneSight clinicians

Genesight is incredibly beneficial for difficult to treat patients

Visuals

Myriad Genetics logo

Full-color, white, and black

GeneSight logo

Full-color, white, and black

Take the next step